{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T02:32:38Z","timestamp":1721615558428},"reference-count":10,"publisher":"Japanese Society of Internal Medicine","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,7,1]]},"DOI":"10.2169\/internalmedicine.6704-20","type":"journal-article","created":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T22:14:36Z","timestamp":1625091276000},"page":"2093-2095","source":"Crossref","is-referenced-by-count":2,"title":["Combination Therapy Using Sodium Zirconium Cyclosilicate and a Mineralocorticoid Receptor Antagonist in Patients with Heart Failure and Hyperkalemia"],"prefix":"10.2169","volume":"60","author":[{"given":"Teruhiko","family":"Imamura","sequence":"first","affiliation":[{"name":"The Second Department of Internal Medicine, University of Toyama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Oshima","sequence":"additional","affiliation":[{"name":"The Second Department of Internal Medicine, University of Toyama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikhil","family":"Narang","sequence":"additional","affiliation":[{"name":"Advocate Christ Medical Center, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichi","family":"Ushijima","sequence":"additional","affiliation":[{"name":"The Second Department of Internal Medicine, University of Toyama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Ueno","sequence":"additional","affiliation":[{"name":"The Second Department of Internal Medicine, University of Toyama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Ueno","sequence":"additional","affiliation":[{"name":"The Second Department of Internal Medicine, University of Toyama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Kinugawa","sequence":"additional","affiliation":[{"name":"The Second Department of Internal Medicine, University of Toyama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341: 709-717, 1999.","DOI":"10.1056\/NEJM199909023411001"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Zannad F, McMurray JJ, Krum H, et al. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 364: 11-21, 2011.","DOI":"10.1056\/NEJMoa1009492"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Pitt B, Pfeffer MA, Assmann SF, et al. Spironolactone for heart failure with preserved ejection fraction. N Engl J Med 370: 1383-1392, 2014.","DOI":"10.1056\/NEJMoa1313731"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Ito S, Itoh H, Rakugi H, Okuda Y, Yoshimura M, Yamakawa S. Double-blind randomized phase 3 study comparing esaxerenone (CS-3150) and eplerenone in patients with essential hypertension (ESAX-HTN study). Hypertension 75: 51-58, 2020.","DOI":"10.1161\/HYPERTENSIONAHA.119.13569"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Shah KB, Rao K, Sawyer R, Gottlieb SS. The adequacy of laboratory monitoring in patients treated with spironolactone for congestive heart failure. J Am Coll Cardiol 46: 845-849, 2005.","DOI":"10.1016\/j.jacc.2005.06.010"},{"key":"6","unstructured":"6. Eschalier R, McMurray JJ, Swedberg K, et al. Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and\/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (eplerenone in mild patients hospitalization and survival study in heart failure). J Am Coll Cardiol 62: 1585-1593, 2013."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Zannad F, Hsu BG, Maeda Y, et al. Efficacy and safety of sodium zirconium cyclosilicate for hyperkalaemia: the randomized, placebo-controlled HARMONIZE-Global study. ESC Heart Fail 7: 54-64, 2020.","DOI":"10.1002\/ehf2.12561"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Fishbane S, Ford M, Fukagawa M, et al. A phase 3b, randomized, double-blind, placebo-controlled study of sodium zirconium cyclosilicate for reducing the incidence of predialysis hyperkalemia. J Am Soc Nephrol 30: 1723-1733, 2020.","DOI":"10.1681\/ASN.2019050450"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Collins AJ, Pitt B, Reaven N, et al. Association of serum potassium with all-cause mortality in patients with and without heart failure, chronic kidney disease, and\/or diabetes. Am J Nephrol 46: 213-221, 2017.","DOI":"10.1159\/000479802"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ferreira JP, Butler J, Rossignol P, et al. Abnormalities of potassium in heart failure: JACC state-of-the-art review. J Am Coll Cardiol 75: 2836-2850, 2020.","DOI":"10.1016\/j.jacc.2020.04.021"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/13\/60_6704-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T06:00:31Z","timestamp":1672639231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/13\/60_6704-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,1]]},"references-count":10,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6704-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,1]]},"article-number":"6704-20"}}